Physician
Palmisciano, Lynne
Palmisciano, Lynne was paid $1.31M by Medicaid between Feb 2018 and Dec 2024, across 6 billing codes. Its largest line is 99283, emergency room visit (moderate) — 60% of everything it billed.
33Billing provider infoPALMISCIANO, LYNNE
PROVIDENCE, RI 02903
PROVIDENCE, RI 02903
33aNPI1184638017assigned 07/28/2006
33bProvider typePediatric Emergency Medicine (Pediatrics) Physician
28Total paid$1.31M
24GClaims7,895
24DCodes billed6
24AFirst – last monthFeb 2018 – Dec 2024
Compared with peers
Next to other Pediatric Emergency Medicine (Pediatrics) Physician providers in Rhode Island
Rank by total paid#1 of 6
Median peer was paid$350K
This provider vs. median3.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 755 | $58K | |
| 2019 | 479 | $48K | |
| 2020 | 648 | $105K | |
| 2021 | 1,315 | $244K | |
| 2022 | 1,571 | $267K | |
| 2023 | 1,668 | $286K | |
| 2024incomplete | 1,459 | $298K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 60% | 4,062 | 3,969 | $780K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 22% | 2,570 | 2,513 | $288K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 821 | 802 | $163K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.5% | 415 | 359 | $72K |
| 99223 | Prolong inpt eval add15 m | <1% | 13 | 13 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 14 | 13 | $2K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.